The histological assessment has been advocated as a detailed and accurate measure of
disease activity in inflammatory bowel diseases (IBD). In ulcerative colitis (UC), histological …

For decades, the therapeutic goal of conventional treatment among inflammatory bowel
disease (IBD) patients is alleviating exacerbations in acute phase, maintaining remission …

Abstract Background and Aims Histological disease activity in inflammatory bowel disease
[IBD] is associated with clinical outcomes and is an important endpoint in drug development …

Integrating artificial intelligence into inflammatory bowel disease (IBD) has the potential to
revolutionise clinical practice and research. Artificial intelligence harnesses advanced …

Background & Aims Individuals with inflammatory bowel disease (IBD) are at increased risk
of serious infections, but whether this risk varies by histologic disease activity is unclear …

Introduction The STRIDE consensus suggested to focus on mucosal healing, based on
biomarkers and endoscopy, in addition to clinical endpoints as treatment target. This …

Introduction Treatment goals for ulcerative colitis (UC) are evolving from the achievement of
clinical remission to more rigorous goals defined by endoscopic and histologic healing …

Mucosal healing (MH) is the main treatment target in ulcerative colitis (UC) and Crohn's
disease, and it is defined by the combination of complete endoscopic and histologic …

Background & Aims Histologic evaluation of mucosal healing in Crohn's disease is an
evolving treatment target. We evaluated histologic outcomes for mirikizumab efficacy and …

Background Inflammatory bowel disease (IBD) has been linked to adverse pregnancy
outcomes, but it is unclear how risks vary by histological activity. Methods We performed a …